Cargando…
Interleukin‐1 blockade treatment decreasing cardiovascular risk
BACKGROUND: Interleukin‐1 (IL‐1) played a role in the occurrence and development of atherosclerosis and cardiovascular events. However, the association between IL‐1 blockage treatment and reducing of cardiovascular risk remains poorly defined. HYPOTHESIS: IL‐1 blockage treatment reduce the risk and...
Autores principales: | Zheng, Zi‐Heng, Zeng, Xun, Nie, Xiao‐Ying, Cheng, Yun‐Jiu, Liu, Jun, Lin, Xiao‐Xiong, Yao, Hao, Ji, Cheng‐Cheng, Chen, Xu‐Miao, Jun, Fan, Wu, Su‐Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788469/ https://www.ncbi.nlm.nih.gov/pubmed/31415103 http://dx.doi.org/10.1002/clc.23246 |
Ejemplares similares
-
Long‐Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer
por: Cheng, Yun‐Jiu, et al.
Publicado: (2017) -
Association of early repolarization pattern with cardiovascular outcomes in middle‐aged population: A cohort study
por: Cheng, Yun‐Jiu, et al.
Publicado: (2020) -
Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
por: Li, Wei-Jie, et al.
Publicado: (2015) -
SCN1Bβ mutations that affect their association with Kv4.3 underlie early repolarization syndrome
por: Yao, Hao, et al.
Publicado: (2018) -
Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)